Carl Zeiss Meditec AG (ETR:AFX) Given a €40.00 Price Target by Deutsche Bank AG Analysts

Carl Zeiss Meditec AG (ETR:AFX) has been given a €40.00 ($47.06) price objective by investment analysts at Deutsche Bank AG in a report released on Tuesday. The firm presently has a “neutral” rating on the stock.

A number of other equities analysts also recently commented on the company. Nord/LB set a €52.00 ($61.18) price objective on Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research report on Friday, June 2nd. Independent Research GmbH set a €44.00 ($51.76) price objective on Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a research report on Saturday, May 20th. Commerzbank Ag set a €42.00 ($49.41) price objective on Carl Zeiss Meditec AG and gave the stock a “neutral” rating in a research report on Saturday, May 20th. Berenberg Bank set a €48.00 ($56.47) price objective on Carl Zeiss Meditec AG and gave the stock a “buy” rating in a research report on Monday, May 29th. Finally, Kepler Capital Markets set a €48.50 ($57.06) target price on Carl Zeiss Meditec AG and gave the company a “buy” rating in a research report on Saturday, May 20th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of €45.75 ($53.82).

Carl Zeiss Meditec AG (ETR AFX) opened at 41.87 on Tuesday. Carl Zeiss Meditec AG has a 12-month low of €30.80 and a 12-month high of €47.80. The company has a 50-day moving average price of €45.31 and a 200-day moving average price of €42.43. The stock has a market capitalization of €3.74 billion and a PE ratio of 30.45.

ILLEGAL ACTIVITY NOTICE: “Carl Zeiss Meditec AG (ETR:AFX) Given a €40.00 Price Target by Deutsche Bank AG Analysts” was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://sportsperspectives.com/2017/08/10/carl-zeiss-meditec-ag-etrafx-given-a-40-00-price-target-by-deutsche-bank-ag-analysts.html.

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG is a Germany-based medical technology and device company. It offers offers complete solutions to diagnose and treat ophtalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The Company operates in two segments: Ophthalmic Devices and Microsurgery.

Analyst Recommendations for Carl Zeiss Meditec AG (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply